Boston Scientific Corporation (0HOY.L)
USD 89.2
(-1.53%)
USD 89.2
(-1.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.13 Billion USD | 8.21% |
| 2022 | 32.46 Billion USD | 0.74% |
| 2021 | 32.22 Billion USD | 4.72% |
| 2020 | 30.77 Billion USD | 0.69% |
| 2019 | 30.56 Billion USD | 45.55% |
| 2018 | 20.99 Billion USD | 10.28% |
| 2017 | 19.04 Billion USD | 5.23% |
| 2016 | 18.09 Billion USD | -0.2% |
| 2015 | 18.13 Billion USD | 6.51% |
| 2014 | 17.02 Billion USD | 2.73% |
| 2013 | 16.57 Billion USD | -3.4% |
| 2012 | 17.15 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 36.66 Billion USD | 4.36% |
| 2024 Q2 | 37.1 Billion USD | 1.2% |
| 2024 Q3 | 38.07 Billion USD | 2.61% |
| 2023 FY | 35.13 Billion USD | 8.21% |
| 2023 Q4 | 35.13 Billion USD | 3.21% |
| 2023 Q2 | 33.6 Billion USD | 2.16% |
| 2023 Q3 | 34.04 Billion USD | 1.32% |
| 2023 Q1 | 32.89 Billion USD | 1.3% |
| 2022 Q4 | 32.46 Billion USD | 1.63% |
| 2022 Q2 | 32.18 Billion USD | -0.46% |
| 2022 Q1 | 32.33 Billion USD | 0.34% |
| 2022 FY | 32.46 Billion USD | 0.74% |
| 2022 Q3 | 31.94 Billion USD | -0.75% |
| 2021 Q2 | 31.16 Billion USD | 0.87% |
| 2021 Q4 | 32.22 Billion USD | 1.1% |
| 2021 FY | 32.22 Billion USD | 4.72% |
| 2021 Q3 | 31.87 Billion USD | 2.27% |
| 2021 Q1 | 30.9 Billion USD | 0.4% |
| 2020 FY | 30.77 Billion USD | 0.69% |
| 2020 Q1 | 30.11 Billion USD | -1.48% |
| 2020 Q2 | 30.82 Billion USD | 2.36% |
| 2020 Q4 | 30.77 Billion USD | -0.22% |
| 2020 Q3 | 30.84 Billion USD | 0.07% |
| 2019 Q3 | 26.75 Billion USD | 10.07% |
| 2019 Q2 | 24.3 Billion USD | 2.13% |
| 2019 FY | 30.56 Billion USD | 45.55% |
| 2019 Q1 | 23.8 Billion USD | 13.35% |
| 2019 Q4 | 30.56 Billion USD | 14.24% |
| 2018 Q2 | 19.61 Billion USD | 2.15% |
| 2018 Q1 | 19.2 Billion USD | 0.84% |
| 2018 FY | 20.99 Billion USD | 10.28% |
| 2018 Q4 | 20.99 Billion USD | 3.04% |
| 2018 Q3 | 20.37 Billion USD | 3.89% |
| 2017 Q4 | 19.04 Billion USD | 2.18% |
| 2017 FY | 19.04 Billion USD | 5.23% |
| 2017 Q2 | 18.38 Billion USD | 2.45% |
| 2017 Q1 | 17.94 Billion USD | -0.85% |
| 2017 Q3 | 18.63 Billion USD | 1.38% |
| 2016 Q1 | 17.71 Billion USD | -2.29% |
| 2016 Q4 | 18.09 Billion USD | 2.25% |
| 2016 Q3 | 17.69 Billion USD | -0.79% |
| 2016 Q2 | 17.83 Billion USD | 0.68% |
| 2016 FY | 18.09 Billion USD | -0.2% |
| 2015 Q2 | 17.12 Billion USD | 3.95% |
| 2015 FY | 18.13 Billion USD | 6.51% |
| 2015 Q4 | 18.13 Billion USD | -0.45% |
| 2015 Q3 | 18.21 Billion USD | 6.38% |
| 2015 Q1 | 16.47 Billion USD | -3.24% |
| 2014 Q2 | 16.47 Billion USD | 0.87% |
| 2014 Q3 | 16.71 Billion USD | 1.46% |
| 2014 Q4 | 17.02 Billion USD | 1.83% |
| 2014 FY | 17.02 Billion USD | 2.73% |
| 2014 Q1 | 16.33 Billion USD | -1.42% |
| 2013 Q2 | 16.99 Billion USD | 1.39% |
| 2013 Q1 | 16.76 Billion USD | -2.28% |
| 2013 FY | 16.57 Billion USD | -3.4% |
| 2013 Q3 | 16.91 Billion USD | -0.46% |
| 2013 Q4 | 16.57 Billion USD | -2.05% |
| 2012 Q4 | 17.15 Billion USD | 0.0% |
| 2012 FY | 17.15 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -9368.451% |
| Accuray Incorporated | 468.62 Million USD | -7397.647% |
| Align Technology, Inc. | 6.08 Billion USD | -477.526% |
| Elevance Health Inc. | 108.92 Billion USD | 67.744% |
| AxoGen, Inc. | 196.82 Million USD | -17751.209% |
| CVS Health Corporation | 249.72 Billion USD | 85.93% |
| Cardinal Health, Inc. | 45.12 Billion USD | 22.129% |
| Centene Corporation | 84.64 Billion USD | 58.488% |
| DaVita Inc. | 17.61 Billion USD | -99.416% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 37.493% |
| Hologic, Inc. | 9.15 Billion USD | -283.748% |
| Humana Inc. | 47.06 Billion USD | 25.346% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -977.816% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -110.079% |
| Masimo Corporation | 3.04 Billion USD | -1055.219% |
| McKesson Corporation | 67.44 Billion USD | 47.903% |
| Patterson Companies, Inc. | 2.96 Billion USD | -1083.404% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -150.578% |
| ResMed Inc. | 6.87 Billion USD | -411.263% |
| Henry Schein, Inc. | 10.57 Billion USD | -232.318% |
| Teladoc Health, Inc. | 4.39 Billion USD | -699.933% |
| Universal Health Services, Inc. | 14.35 Billion USD | -144.733% |
| Veeva Systems Inc. | 5.91 Billion USD | -494.425% |
| Baxter International Inc. | 28.27 Billion USD | -24.261% |
| Becton, Dickinson and Company | 52.78 Billion USD | 33.429% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -127.543% |
| Danaher Corporation | 84.48 Billion USD | 58.413% |
| Stryker Corporation | 39.91 Billion USD | 11.966% |
| Medtronic plc | 89.98 Billion USD | 60.952% |